Cash flow Pure Health Holding

Stocks

PUREHEALTH

AEE01362P238

Healthcare Facilities & Services

Market Closed - Abu Dhabi Securities Exchange Other stock markets 04:25:19 22/07/2026 pm IST			5-day change	1st Jan Change
2.220 ^AED	+0.45%		-1.33%	-12.94%

01/05	UAE Stocks in Green as US-Iran War Risks Resurface	MT
01/05	Pure Health remains well positioned to deliver sustainable growth	RE

e1c645cdb32b630f111897bb2d7d.uwKP7CWOEFhrRNsxzjbEhBpLH0_GAsX5jiOD2ggG0uA.4mb8llzrJXU7DYtBig6w0yoHaz2tVbTN20y7jkZwuansdPefTsMlbwUMjg

Published financial data: PURE HEALTH HOLDING

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2022	2023	2024	2025
Revenues	1.23TCr	1.64TCr	2.58TCr	2.73TCr
Total Revenues	1.23TCr	1.64TCr	2.58TCr	2.73TCr
Cost of Goods Sold, Total	757.89Cr	1.38TCr	1.92TCr	2.06TCr
Gross Profit	471.61Cr	255.89Cr	663.58Cr	673.27Cr
Selling General & Admin Expenses, Total	239.4Cr	377.57Cr	465.91Cr	477.51Cr
Other Operating Expenses	-151.21Cr	-271.86Cr	-63Cr	-71Cr
Other Operating Expenses, Total	88Cr	105.71Cr	402.63Cr	406.63Cr
Operating Income	383.42Cr	150.17Cr	260.95Cr	266.64Cr
Interest Expense, Total	-4.6Cr	-12Cr	-83Cr	-85Cr
Interest And Investment Income	-	-	-	34Cr
Net Interest Expenses	-4.6Cr	-12Cr	-83Cr	-51Cr
Other Non Operating Income (Expenses)	-	-	-2.24Cr	-1.22Cr
EBT, Excl. Unusual Items	378.82Cr	138.43Cr	176.19Cr	214.18Cr
Impairment of Goodwill	-3L	-	-	-
Gain (Loss) On Sale Of Investments	-	-	5.63Cr	4.39Cr
Gain (Loss) On Sale Of Assets	-1.91Cr	-6L	2.54Cr	1.22Cr
Asset Writedown	-70.12L	-	-6.58Cr	4.33Cr
Other Unusual Items	48Cr	-	-	8L
EBT, Incl. Unusual Items	424.28Cr	138.36Cr	177.78Cr	224.21Cr
Income Tax Expense	-	42Cr	6.2Cr	22Cr
Earnings From Continuing Operations	424.28Cr	96Cr	171.57Cr	202.01Cr
Net Income to Company	424.28Cr	96Cr	171.57Cr	202.01Cr
Minority Interest	-57Cr	-3L	-40.85L	-1.8Cr
Net Income - (IS)	367.53Cr	96Cr	171.16Cr	200.21Cr
Net Income to Common Incl Extra Items	367.53Cr	96Cr	171.16Cr	200.21Cr
Net Income to Common Excl. Extra Items	367.53Cr	96Cr	171.16Cr	200.21Cr
Per Share Items
Net EPS - Basic	28.99	0.1	0.15	0.18
Basic EPS - Continuing Operations	28.99	0.1	0.15	0.18
Basic Weighted Average Shares Outstanding	13Cr	1TCr	1.11TCr	1.11TCr
Net EPS - Diluted	28.99	0.1	0.15	0.18
Diluted EPS - Continuing Operations	28.99	0.1	0.15	0.18
Diluted Weighted Average Shares Outstanding	13Cr	1TCr	1.11TCr	1.11TCr
Normalized Basic EPS	14.2	0.09	0.1	0.12
Normalized Diluted EPS	14.2	0.09	0.1	0.12
Dividend Per Share	-	-	0.03	0.05
Payout Ratio	83.2	31.1	-	17.5
Supplemental Items
EBITDA	411.91Cr	222.09Cr	348.05Cr	352.98Cr
EBITA	392.77Cr	165.63Cr	285.54Cr	283.35Cr
EBIT	383.42Cr	150.17Cr	260.95Cr	266.64Cr
Effective Tax Rate - (Ratio)	-	30.26	3.49	9.9
Current Domestic Taxes	-	-	18Cr	37Cr
Total Current Taxes	-	-	18Cr	37Cr
Deferred Domestic Taxes	-	42Cr	-12Cr	-15Cr
Total Deferred Taxes	-	42Cr	-12Cr	-15Cr
Normalized Net Income	180.02Cr	86Cr	109.71Cr	132.07Cr
Interest on Long-Term Debt	4.6Cr	12Cr	83Cr	85Cr
Non-Cash Pension Expense	1.33Cr	6.59Cr	6.22Cr	-
Supplemental Operating Expense Items
Selling and Marketing Expenses	2.96Cr	4.39Cr	5.93Cr	12Cr
General and Administrative Expenses	236.44Cr	373.18Cr	459.99Cr	465.19Cr

Fiscal Period: December	2022	2023	2024	2025
Assets
Cash And Equivalents	700.81Cr	1.06TCr	1.2TCr	770.6Cr
Short Term Investments	-	-	27Cr	-
Trading Asset Securities, Total	36Cr	35Cr	-	21.24L
Total Cash And Short Term Investments	736.78Cr	1.09TCr	1.22TCr	770.81Cr
Accounts Receivable, Total	283.08Cr	270.13Cr	662.02Cr	765.82Cr
Other Receivables	476.09Cr	253.69Cr	117.82Cr	165.16Cr
Total Receivables	759.17Cr	523.82Cr	779.84Cr	930.98Cr
Inventory	60Cr	74Cr	118.36Cr	141.65Cr
Prepaid Expenses	27Cr	25Cr	-	-
Other Current Assets, Total	128.57Cr	144.38Cr	152.69Cr	158.64Cr
Total Current Assets	1.71TCr	1.86TCr	2.27TCr	2TCr
Gross Property Plant And Equipment	745.52Cr	748.75Cr	1.87TCr	2.51TCr
Accumulated Depreciation	-409.13Cr	-441.76Cr	-438.51Cr	-501.86Cr
Net Property Plant And Equipment	336.39Cr	306.99Cr	1.43TCr	2.01TCr
Long-term Investments	27Cr	213.15Cr	261.8Cr	396.03Cr
Goodwill	134.21Cr	134.21Cr	464.21Cr	750.66Cr
Other Intangibles, Total	317.89Cr	304.08Cr	400.19Cr	506.17Cr
Accounts Receivable Long-Term	27.24L	12.6L	-	-
Deferred Tax Assets Long-Term	-	-	20Cr	49Cr
Other Long-Term Assets, Total	52.94L	46.96L	8.61Cr	5.06Cr
Total Assets	2.53TCr	2.82TCr	4.86TCr	5.72TCr
Liabilities
Accounts Payable, Total	117.78Cr	136.93Cr	165.11Cr	937.38Cr
Accrued Expenses, Total	280.67Cr	153.78Cr	388.64Cr	12Cr
Current Portion of Long-Term Debt	47.73L	49.62L	2.62Cr	42Cr
Current Portion of Leases	15Cr	4.58Cr	31Cr	50Cr
Current Income Taxes Payable	-	-	18Cr	38Cr
Unearned Revenue Current, Total	175.29Cr	65Cr	22Cr	6.08Cr
Other Current Liabilities	468.52Cr	462.2Cr	580.38Cr	395.55Cr
Total Current Liabilities	1.06TCr	822.6Cr	1.21TCr	1.48TCr
Long-Term Debt	29Cr	28Cr	183.4Cr	283.36Cr
Long-Term Leases	145.99Cr	162.04Cr	1.22TCr	1.45TCr
Unearned Revenue Non Current	4.21Cr	9.35Cr	-	-
Pension & Other Post Retirement Benefits	162.08Cr	147.43Cr	158.9Cr	171.99Cr
Deferred Tax Liability Non Current	-	42Cr	102.51Cr	179.7Cr
Other Non Current Liabilities	-	-	10Cr	320.71Cr
Total Liabilities	1.4TCr	1.21TCr	2.88TCr	3.88TCr
Common Stock, Total	50Cr	1.11TCr	1.11TCr	1.11TCr
Additional Paid In Capital	1.12TCr	250.77Cr	250.77Cr	250.77Cr
Retained Earnings	144.92Cr	235.3Cr	419.12Cr	543.51Cr
Comprehensive Income and Other	-188Cr	8.1Cr	190.42Cr	-75Cr
Total Common Equity	1.13TCr	1.61TCr	1.97TCr	1.83TCr
Minority Interest	38.35L	41.72L	2.21Cr	2.02Cr
Total Equity	1.13TCr	1.61TCr	1.97TCr	1.83TCr
Total Liabilities And Equity	2.53TCr	2.82TCr	4.86TCr	5.72TCr
Supplemental Items
ECS Total Shares Outstanding on Filing Date	50Cr	1.11TCr	1.11TCr	1.11TCr
ECS Total Common Shares Outstanding	50Cr	1.11TCr	1.11TCr	1.11TCr
Book Value / Share	22.57	1.44	1.77	1.65
Tangible Book Value	676.31Cr	1.17TCr	1.11TCr	573.3Cr
Tangible Book Value Per Share	13.53	1.05	1	0.52
Total Debt	190.27Cr	195.59Cr	1.44TCr	1.82TCr
Net Debt	-546.51Cr	-895.5Cr	215.02Cr	1.05TCr
Debt Equivalent of Unfunded Proj. Benefit Obligation	-	-	-2.94Cr	-
Minority Interest, Total (Incl. Fin. Div)	38.35L	41.72L	2.21Cr	2.02Cr
Equity Method Investments, Total	4.59Cr	186.52Cr	4.03Cr	13Cr
Account Code - Inventory Valuation	6	6	6	6
Inventories - Others	99Cr	102.38Cr	129.65Cr	154.31Cr
Land - (BS)	-	-	-	143.94Cr
Machinery, Total	453.41Cr	448.56Cr	543.03Cr	635.9Cr
Accumulated Allowance for Doubtful Accounts (Supple)	18Cr	8.36Cr	-	-

Fiscal Period: December	2022	2023	2024	2025
Net Income	367.53Cr	96Cr	171.16Cr	200.21Cr
Depreciation & Amortization - CF	27Cr	76Cr	125.37Cr	153.37Cr
Amortization of Goodwill and Intangible Assets - (CF)	9.35Cr	15Cr	25Cr	17Cr
Depreciation & Amortization, Total	36Cr	92Cr	149.95Cr	170.08Cr
Amortization of Deferred Charges, Total - (CF)	2.16Cr	4.93Cr	6.09Cr	11Cr
(Gain) Loss From Sale Of Asset	1.91Cr	6L	-2.54Cr	-1.22Cr
(Gain) Loss on Sale of Investments - (CF)	-54.39L	87.13L	-1.18Cr	-4.39Cr
Asset Writedown & Restructuring Costs	72.77L	2L	6.69Cr	-3.21Cr
(Income) Loss On Equity Investments - (CF)	-3L	-2.52Cr	-14Cr	-2.02Cr
Provision and Write-off of Bad Debts	-1.32Cr	16Cr	28Cr	15Cr
Other Operating Activities, Total	38Cr	26Cr	68Cr	59Cr
Change In Accounts Receivable	226.27Cr	113.63Cr	-29Cr	-3.72Cr
Change In Inventories	6.55Cr	-15Cr	-23Cr	-15Cr
Change In Accounts Payable	-149.39Cr	-96Cr	136.45Cr	55Cr
Change in Unearned Revenues	-	-	1.74Cr	41.99L
Change in Other Net Operating Assets	-106.42Cr	17Cr	-83Cr	12Cr
Cash from Operations	421.45Cr	253.1Cr	416.34Cr	492.91Cr
Capital Expenditure	-23Cr	-39Cr	-78Cr	-94Cr
Sale of Property, Plant, and Equipment	32T	1L	41.48L	2.26Cr
Cash Acquisitions	555.58Cr	4.48Cr	-273.08Cr	-319.81Cr
Divestitures	-	-14.93L	-6.27Cr	-
Sale (Purchase) of Intangible assets	-2.74Cr	-5.85Cr	-18Cr	-18Cr
Investment in Marketable and Equity Securities, Total	-164.46Cr	-222.74Cr	-24Cr	-229.76Cr
Net (Increase) Decrease in Loans Originated / Sold - Investing	27.24L	14.63L	-	-
Other Investing Activities, Total	-	15Cr	33Cr	34Cr
Cash from Investing	365.54Cr	-248.2Cr	-365.28Cr	-625.01Cr
Long-Term Debt Issued, Total	-	-	183.03Cr	18Cr
Total Debt Issued	-	-	183.03Cr	18Cr
Short Term Debt Repaid, Total	-	-11Cr	-	-
Long-Term Debt Repaid, Total	-3.97Cr	-9Cr	-147.95Cr	-283.5Cr
Total Debt Repaid	-3.97Cr	-20Cr	-147.95Cr	-283.5Cr
Issuance of Common Stock	-	361.89Cr	-	1.85Cr
Repurchase of Common Stock	-	-	-	-2.12Cr
Common Dividends Paid	-305.8Cr	-30Cr	-	-35Cr
Common & Preferred Stock Dividends Paid	-305.8Cr	-30Cr	-	-35Cr
Other Financing Activities, Total	3.14Cr	2.02Cr	-5.11Cr	-9.28Cr
Cash from Financing	-306.63Cr	313.87Cr	30Cr	-310.57Cr
Foreign Exchange Rate Adjustments	-	-	-83.37L	6.2Cr
Net Change in Cash	480.37Cr	318.76Cr	80Cr	-436.47Cr
Supplemental Items
Cash Interest Paid	1.88Cr	3.82Cr	11Cr	9.28Cr
Cash Income Tax Paid (Refund)	-	-	-	24Cr
Levered Free Cash Flow	-	125.09Cr	245.82Cr	213.62Cr
Unlevered Free Cash Flow	-	132.43Cr	297.4Cr	266.91Cr
Change In Net Working Capital	-	13Cr	-74Cr	-31Cr
Net Debt Issued / Repaid	-3.97Cr	-20Cr	35Cr	-265.98Cr

Fiscal Period: December	2022	2023	2024	2025
Profitability
Return on Assets	-	3.59	4.25	3.15
Return on Total Capital	-	6.01	6.26	4.72
Return On Equity %	-	7.05	9.59	10.62
Return on Common Equity	-	7.05	9.57	10.53
Margin Analysis
Gross Profit Margin %	38.36	15.6	25.67	24.65
SG&A Margin	19.47	23.02	18.02	17.48
EBITDA Margin %	33.5	13.54	13.46	12.92
EBITA Margin %	31.95	10.1	11.05	10.37
EBIT Margin %	31.18	9.16	10.1	9.76
Income From Continuing Operations Margin %	34.51	5.88	6.64	7.4
Net Income Margin %	29.89	5.88	6.62	7.33
Net Avail. For Common Margin %	29.89	5.88	6.62	7.33
Normalized Net Income Margin	14.64	5.27	4.24	4.84
Levered Free Cash Flow Margin	-	7.63	9.51	7.82
Unlevered Free Cash Flow Margin	-	8.08	11.51	9.77
Asset Turnover
Asset Turnover	-	0.63	0.67	0.52
Fixed Assets Turnover	-	5.1	2.98	1.59
Receivables Turnover (Average Receivables)	-	5.82	4.33	3.83
Inventory Turnover (Average Inventory)	-	20.63	19.96	15.83
Short Term Liquidity
Current Ratio	1.62	2.26	1.88	1.35
Quick Ratio	1.41	1.96	1.66	1.15
Operating Cash Flow to Current Liabilities	0.4	0.31	0.34	0.33
Days Sales Outstanding (Average Receivables)	-	62.73	84.49	95.23
Days Outstanding Inventory (Average Inventory)	-	17.69	18.33	23.06
Average Days Payable Outstanding	-	33.25	28.12	149.41
Cash Conversion Cycle (Average Days)	-	47.17	74.71	-31.12
Long Term Solvency
Total Debt/Equity	16.86	12.18	72.82	99.47
Total Debt / Total Capital	14.42	10.86	42.14	49.87
LT Debt/Equity	15.5	11.86	71.13	94.47
Long-Term Debt / Total Capital	13.26	10.58	41.16	47.36
Total Liabilities / Total Assets	55.34	43.01	59.37	67.95
EBIT / Interest Expense	83.36	12.78	3.16	3.13
EBITDA / Interest Expense	91.16	20.58	4.98	5.12
(EBITDA - Capex) / Interest Expense	86.13	17.25	4.04	4.02
Total Debt / EBITDA	0.45	0.81	3.5	4.17
Net Debt / EBITDA	-1.3	-3.7	0.52	2.41
Total Debt / (EBITDA - Capex)	0.48	0.97	4.31	5.32
Net Debt / (EBITDA - Capex)	-1.38	-4.42	0.65	3.07
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-	31.34	57.62	5.66
Gross Profit, 1 Yr. Growth %	-	-47.02	93.86	1.31
EBITDA, 1 Yr. Growth %	-	-46.69	56.71	11.54
EBITA, 1 Yr. Growth %	-	-58.33	72.4	11.58
EBIT, 1 Yr. Growth %	-	-61.31	73.77	16.25
Earnings From Cont. Operations, 1 Yr. Growth %	-	-77.49	77.8	17.74
Net Income, 1 Yr. Growth %	-	-74.06	77.44	16.97
Normalized Net Income, 1 Yr. Growth %	-	-52.75	26.85	21.19
Diluted EPS Before Extra, 1 Yr. Growth %	-	-74.59	60.28	16.97
Accounts Receivable, 1 Yr. Growth %	-	-7.97	24.57	16.15
Inventory, 1 Yr. Growth %	-	23.48	59.66	19.68
Net Property, Plant and Equip., 1 Yr. Growth %	-	-8.74	365.68	40.38
Total Assets, 1 Yr. Growth %	-	16.88	72.41	17.68
Tangible Book Value, 1 Yr. Growth %	-	71.46	-5.14	-48.21
Common Equity, 1 Yr. Growth %	-	41.72	22.81	-7.17
Cash From Operations, 1 Yr. Growth %	-	-39.54	64.4	16.83
Capital Expenditures, 1 Yr. Growth %	-	68.98	99.13	20.75
Levered Free Cash Flow, 1 Yr. Growth %	-	-	92.74	-6.62
Unlevered Free Cash Flow, 1 Yr. Growth %	-	-	124.57	-4.79
Dividend Per Share, 1 Yr. Growth %	-	-	-	74.94
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-	-	43.88	29.05
Gross Profit, 2 Yr. CAGR %	-	-	17.22	40.25
EBITDA, 2 Yr. CAGR %	-	-	-8.6	26.07
EBITA, 2 Yr. CAGR %	-	-	-15.25	30.8
EBIT, 2 Yr. CAGR %	-	-	-18	33.25
Earnings From Cont. Operations, 2 Yr. CAGR %	-	-	-36.73	44.69
Net Income, 2 Yr. CAGR %	-	-	-32.15	44.06
Normalized Net Income, 2 Yr. CAGR %	-	-	-22.58	23.57
Diluted EPS Before Extra, 2 Yr. CAGR %	-	-	-36.18	36.92
Accounts Receivable, 2 Yr. CAGR %	-	-	50.18	20.04
Inventory, 2 Yr. CAGR %	-	-	40.41	38.23
Net Property, Plant and Equip., 2 Yr. CAGR %	-	-	106.15	155.68
Total Assets, 2 Yr. CAGR %	-	-	41.95	42.44
Tangible Book Value, 2 Yr. CAGR %	-	-	27.53	-29.91
Common Equity, 2 Yr. CAGR %	-	-	31.92	6.77
Cash From Operations, 2 Yr. CAGR %	-	-	-0.27	39.51
Capital Expenditures, 2 Yr. CAGR %	-	-	83.43	55.06
Levered Free Cash Flow, 2 Yr. CAGR %	-	-	-	29.42
Unlevered Free Cash Flow, 2 Yr. CAGR %	-	-	-	41.97
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-	-	-	29.81
Gross Profit, 3 Yr. CAGR %	-	-	-	11.71
EBITDA, 3 Yr. CAGR %	-	-	-	-5.38
EBITA, 3 Yr. CAGR %	-	-	-	-10.67
EBIT, 3 Yr. CAGR %	-	-	-	-11.76
Earnings From Cont. Operations, 3 Yr. CAGR %	-	-	-	-22.18
Net Income, 3 Yr. CAGR %	-	-	-	-18.65
Normalized Net Income, 3 Yr. CAGR %	-	-	-	-10.31
Diluted EPS Before Extra, 3 Yr. CAGR %	-	-	-	-21.9
Accounts Receivable, 3 Yr. CAGR %	-	-	-	37.67
Inventory, 3 Yr. CAGR %	-	-	-	33.13
Net Property, Plant and Equip., 3 Yr. CAGR %	-	-	-	81.37
Total Assets, 3 Yr. CAGR %	-	-	-	33.35
Tangible Book Value, 3 Yr. CAGR %	-	-	-	-5.56
Common Equity, 3 Yr. CAGR %	-	-	-	17.34
Cash From Operations, 3 Yr. CAGR %	-	-	-	5.6
Capital Expenditures, 3 Yr. CAGR %	-	-	-	59.57